SCHEMBL755883

SCHEMBL755883

CC[C@]1(C)CC[C@@H](C(C)C)C[C@H]1C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1270404 0.81
SCHEMBL29024827 0.75
SCHEMBL1569022 0.69
SCHEMBL2983575 0.68
SCHEMBL26537560 0.67
SCHEMBL22905018 0.65
SCHEMBL7750053 0.63 GPBAR1 (0.31)
SCHEMBL12385752 0.63
SCHEMBL19364854 0.63
SCHEMBL26685186 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240324588-A1 ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS Genesee Valley Innovations, LLC 2024-10-03 US claimed
WO-2021216697-A1 EMULSION PROCESSING ZYMERGEN INC. (US) 2021-10-28 WO claimed
US-20200281195-A1 ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS CITIBANK, N.A., AS COLLATERAL AGENT 2020-09-10 US claimed
EP-3705509-A1 ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS Xerox Corporation (US) 2020-09-09 EP claimed
US-20040092583-A1 Treatment for inhibiting neoplastic lesions SHANAHAN-PRENDERGAST ELIZABETH (IE) 2004-05-13 US claimed
EP-1351678-A2 TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS Shanahan-Prendergast, Elizabeth (IE) 2003-10-15 EP claimed
WO-2002053138-A2 TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS SHANAHAN-PRENDERGAST ELISABETH (IE) 2002-07-11 WO claimed
EP-3148345-B1 METHOD FOR REFINING LIPID PHASES, AND USE DREI LILIEN PVG GMBH&CO KG (DE) 2026-04-29 EP disclosed
US-20240324588-A1 ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS Genesee Valley Innovations, LLC 2024-10-03 US disclosed
US-20240319166-A1 Genetically-encoded volatile synthetic biomarkers for breath-based cancer detection THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2024-09-26 US disclosed
CN-117941864-A Cinnamon spice for cigarettes and application of cinnamon spice in cigarette flavoring 广西中烟工业有限责任公司 2024-04-30 CN disclosed
US-11856968-B2 Method for economical removal/fractionation of constituents of vegetal starting materials Dietz, Max (DE) 2024-01-02 US disclosed
WO-2023010143-A2 GENETICALLY-ENCODED VOLATILE SYNTHETIC BIOMARKERS FOR BREATH-BASED CANCER DETECTION THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2023-02-02 WO disclosed
US-6060509-A ADMINISTERING DOSAGE OF TERPENOID PLANT EXTRACT TO TREAT FUNGAL INFECTION IN MAMMAL MILLENNIUM PHARMACEUTICALS, INC. (US) 2000-05-09 US disclosed
EP-0980203-A1 ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES Squires, Meryl (US) 2000-02-23 EP disclosed
US-5932613-A PINE ROOT FUNGAL METABOLITE OR ANALOG MILLENNIUM PHARMACEUTICALS, INC. (US) 1999-08-03 US disclosed
US-5917084-A PINE ROOT (DEUTERO MYCETES) FUNGAL METABOLITE, NATURALLY OCCURRING TERPENOID COMPOUNDS MILLENNIUM PHARMACEUTICALS, INC. (US) 1999-06-29 US disclosed
WO-1998042188-A1 ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES SQUIRES MERYL (US) 1998-10-01 WO disclosed
WO-1998000091-A2 ANTIFUNGAL AGENTS MILLENNIUM PHARMACEUTICALS, INC. (US) 1998-01-08 WO disclosed
WO-1998000121-A1 ANTICANCER AGENTS MILLENNIUM PHARMACEUTICALS, INC. (US) 1998-01-08 WO disclosed